MiSight 1 day: Daily soft contact lens aimed at slowing myopia in children

Responsible: ad hoc news Lifestyle & Consumer Desk. Reviewed prior to publication on June 12, 2026 at 12:46:03 PM ET. Details in the imprint.

MiSight 1 day from CooperCompanies is a daily disposable soft contact lens specifically designed for children with myopia, offering both clear vision correction and a clinically proven approach to slowing the progression of nearsightedness over time. The lens is part of the CooperVision portfolio and is fitted exclusively by licensed eye-care professionals on a prescription basis in the United States. For families weighing between traditional glasses and contact lenses, MiSight 1 day positions itself as an early intervention tool in managing childhood myopia while maintaining everyday comfort and convenience.

How MiSight 1 day works and who it is for

MiSight 1 day is a soft, single-use contact lens worn during waking hours and disposed of at the end of each day, which eliminates the need for cleaning solutions and overnight storage. According to CooperCompanies, the optical design uses concentric treatment zones intended to correct distance vision while also creating specific defocus patterns on the retina, a mechanism that has been associated with slowing the axial elongation of the eye in myopic children. The product targets children typically in the age range where myopia first appears or progresses most quickly, and it is prescribed after a full eye examination and fitting by an optometrist or ophthalmologist.

Compared with standard daily disposable lenses that simply correct refractive error, MiSight 1 day is marketed with a dual purpose: vision correction plus myopia management. That positioning aligns with industry data indicating that global demand for soft contact lenses is growing in step with the rising prevalence of myopia, particularly in younger populations. Parents evaluating options for their children may see this lens as part of a broader strategy recommended by their eye-care provider, which can also include lifestyle adjustments such as more time outdoors and regular vision monitoring.

In the U.S. market, MiSight 1 day is available through participating eye-care practices and authorized distributors rather than over-the-counter retail channels, reflecting its prescription-only status and the need for professional fitting. Pricing is typically structured around annual supply packages in US dollars, and many practices bundle professional services such as follow-up visits into the overall cost. Because contact lens pricing can vary by practice, geography, and insurance coverage, families usually receive a specific quote directly from their provider at the time of fitting. As with most medical devices, any promotional or rebate programs are managed at the practice or manufacturer level and can change over time.

Within CooperCompanies, MiSight 1 day sits in the CooperVision segment, which focuses on soft contact lenses and related products for vision correction. That segment benefits from broader market trends highlighted by independent analyses that project steady growth in soft contact lenses worldwide through the next decade as daily disposables and specialty designs gain share. For CooperCompanies, specialty lenses targeting conditions such as myopia offer a way to differentiate its portfolio in a competitive contact-lens market and deepen relationships with eye-care professionals who serve pediatric patients.

For now, MiSight 1 day plays a role in CooperCompanies broader strategy of addressing eye-health needs through specialty soft lenses, complementing more traditional spherical, toric, and multifocal offerings in its CooperVision lineup. Shares of CooperCompanies (US21664P1039, ticker COO) traded at $67.69 on Nasdaq on June 10, 2026.

This article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.